Foghorn Therapeutics Inc. Insider Transaction

B. Lynne Parshall, a director at Foghorn Therapeutics Inc. (FHTX), acquired 28,000 stock options on June 24, 2026. The options have an exercise price of $4.08 and are set to expire on June 23, 2036. These options vest in full on the first anniversary of the grant date, provided Parshall remains on the board of directors. Following this transaction, Parshall holds 28,000 shares of common stock underlying these options.